Best Performing Healthcare Penny Stocks 2023 USA: FKnol.com

The healthcare sector often produces many high return generating companies, as stocks of the companies working in the pharma, drug discovery, research or associated business have the potential to emerge as winners. Say, if after few years of research work, a small drug research company is able to develop a cure for an ailment or disease which can result in big profits due to patent, copyright and other clauses. The stock price of such a company will shoot through the roof the day it tastes success. Pharma and health sector offers this great potential for producing many multi-bagger stocks. Therefore, investors who are good to make such small-priced bets on such economical-looking, low-cost healthcare stocks do so in expectations of high rewards in the future. These constitute the healthcare penny stocks.
However, one must note that not all such penny stock investments taste success. Majority of them fail, but those which do win offer big potential of not only recouping the losses of losers but also offering great surplus profits.
Penny stocks are those which are trading at a per share price of below $5. Among the various stocks of the U.S.-listed companies belonging to the Healthcare Penny segment, which ones have been the front-runners in terms of generating the highest returns for the investors? Here is the following list comprising of those top 10 America-listed stocks of the 'Healthcare Penny' sector, industry or business segment (or index), which have generated the best returns in terms of price changes between the end of previous year and the date of writing.

Best Performing Stock Screener:

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
Top Performing Healthcare Penny StocksAll Healthcare Penny StocksTop Healthcare Penny Stocks for Oct 2023

Top Healthcare Penny Stocks With Highest Returns

The following list presents stocks of the companies which belong to the broader Healthcare Penny sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:

1) Healthcare Triangle, Inc. (HCTI)

Price Gain: 2,404.17% 2023 year-to-date
Current Market Price: $4.50
52-week Price Range: $1.11 - $10.89
Market Capitalization: $19.25 million

2) Ampio Pharmaceuticals, Inc. (AMPE)

Price Gain: 1,796.09% 2023 year-to-date
Current Market Price: $4.27
52-week Price Range: $3.35 - $27.51
Market Capitalization: $3.22 million
List of ETFs holding AMPE

3) Benitec Biopharma Limited (BNTC)

Price Gain: 1,758.82% 2023 year-to-date
Current Market Price: $3.16
52-week Price Range: $1.86 - $9.01
Market Capitalization: $7.97 million
List of ETFs holding BNTC

4) Adial Pharmaceuticals, Inc. (ADIL)

Price Gain: 1,262.79% 2023 year-to-date
Current Market Price: $2.93
52-week Price Range: $2.65 - $15
Market Capitalization: $3.57 million
List of ETFs holding ADIL

5) Clever Leaves Holdings Inc. (CLVR)

Price Gain: 1,131.27% 2023 year-to-date
Current Market Price: $3.78
52-week Price Range: $3.05 - $25.5
Market Capitalization: $5.76 million

6) Flora Growth Corp. (FLGC)

Price Gain: 1,125.83% 2023 year-to-date
Current Market Price: $2.79
52-week Price Range: $0.17 - $20.6
Market Capitalization: $19.12 million

7) IMAC Holdings, Inc. (BACK)

Price Gain: 1,123.06% 2023 year-to-date
Current Market Price: $2.44
52-week Price Range: $2.25 - $14.4
Market Capitalization: $2.68 million

8) OncoCyte Corporation (OCX)

Price Gain: 894.08% 2023 year-to-date
Current Market Price: $3.19
52-week Price Range: $3.18 - $18.2
Market Capitalization: $26.29 million
List of ETFs holding OCX

9) PainReform Ltd. (PRFX)

Price Gain: 842.57% 2023 year-to-date
Current Market Price: $3.89
52-week Price Range: $0.34 - $26.41
Market Capitalization: $6.06 million

10) Bluejay Diagnostics, Inc. (BJDX)

Price Gain: 705.69% 2023 year-to-date
Current Market Price: $3.06
52-week Price Range: $2.95 - $18.92
Market Capitalization: $3.79 million

☀ Trending Among Corona Carnage ☀ List of Best Performing Drone Stocks, Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks.

Best Performing Stock Screener:

Top Performing Healthcare Penny StocksAll Healthcare Penny StocksTop Healthcare Penny Stocks for Oct 2023

Performance of Top Healthcare Penny Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

Healthcare Triangle, Inc.

Healthcare Triangle, Inc. operates as a healthcare information technology company. It provides a suite of software, solutions, platforms, and services ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Healthcare Triangle, Inc..
Healthcare Triangle, Inc. (HCTI) has moved by 2404.17 percentage over the given period of 2023-YTD, helping it gain a place at number one among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $0.18 apiece to the price of $4.5 per share between the end of December of the previous year and Sep 15, 2023. The smart run of the Pleasanton ,United States-based Health Information Services sector company lead to a handsome gain in its marketcap which changed from $7.48 million to $19.25 million over the same duration.

Ampio Pharma

Ampio Pharmaceuticals, Inc., incorporated on March 24, 2010, is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Ampio Pharma.
The number two spot in the list of top performing stocks of the Healthcare Penny sector is taken by Ampio Pharmaceuticals, Inc. (AMPE). The company's stock price changed from $0.23 per share at the end of December of the previous year to the price of $4.27 per share as of writing. Overall, the stock managed to realized price change of 1796.09 percent during the given time period. The corresponding change in the market capitalization value of the Colorado, CO-based Healthcare sector company was from $3.4 million to $3.22 million. Being ranked in the top 10 best performing stocks of the Healthcare Penny sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.

Benitec Biopharma

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Benitec Biopharma.
Benitec Biopharma (BNTC) generated percentage returns of 1758.82 percent during the 2023 year-to-date. Its returns are based on the share price which moved from $0.17 per share from the previous year-end to the price of $3.16 per share as of Sep 15, 2023. The company's value, as indicated by the market-cap figure, changed from $4.76 million to $7.97 million during the same period.
The company is categorized as a Healthcare speciality business with further classification in the Major Pharmaceuticals sub-category. Based in Australia, the YTD performance of the Healthcare Penny sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.

Adial Pharmaceuticals

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD0 ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Adial Pharmaceuticals.
The Charlottesville, VA-based Healthcare sector company Adial Pharmaceuticals, Inc. (ADIL) holds the number four spot among the best performing stocks of the Healthcare Penny sector. Classified as the Healthcare business, the stock price of Adial Pharmaceuticals ended the previous year at a price of $0.22 per share while it reached the level of $2.93 apiece as of Sep 15, 2023 translating to a percentage change in stock price of 1262.79%. As of writing, the company's market-cap value stands at $3.57 million.

Clever Leaves Holdings Inc.

Clever Leaves Holdings Inc. cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Clever Leaves Holdings Inc..
Based on the market-cap change from $13.55 million to $5.76 million during the given months of the year 2023 and the share price change from $0.31 per share to a price of $3.78 per share as of Sep 15, 2023, Clever Leaves Holdings Inc. (CLVR) was successful in generating YTD returns of 1131.27 percentage. Standing at the number five rank in the top performing list of Healthcare Penny stocks, the New York ,United States-based Clever Leaves Holdings Inc. is categorized as the Drug Manufacturers Specialty & Generic sub-sector business which falls under the larger Healthcare sector.

Flora Growth Corp.

Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Flora Growth Corp..
The Toronto ,Canada-headquartered company Flora Growth Corp. (FLGC) is ranked number six among the best performing stocks of Healthcare Penny of 2023. The Healthcare sector business falls under the Drug Manufacturers Specialty & Generic industrial sub-sector. Since the start of the year 2023, the stock price of Flora Growth Corp. has changed by 1125.83 percent, which is calculated based on the previous year's closing price of $0.23 per share and year-to-date closing price of $2.79 per share as of writing. The market value of the company as indicated by its market-cap changed from $20.46 million to $19.12 million during the same period. Along with Healthcare Penny, the company is also in the business of Health Care, Major Pharmaceuticals, Drug Manufacturers Specialty & Generic, Pharma, Healthcare, among other usual products and services.

IMAC Holdings, Inc.

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of IMAC Holdings, Inc..
During the given months of the year 2023, IMAC Holdings, Inc. (BACK) was successful in generating YTD returns of 1123.06 percentage which helped it gain the number seven spot in the list of the top performing stocks which generated maximum returns during year 2023 till date. As of December of the previous year, the stock of the Brentwood, United States-based IMAC Holdings, Inc. closed at a price of $0.2 per share, while it traded at a price of $2.44 per share as of Sep 15, 2023. The company's market cap changed from $6.54 million to $2.68 million during the same period YTD. The company is classified under the Healthcare industry sector and further specialized as a Medical Care Facilities sector business.

OncoCyte

OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of OncoCyte.
Rank number eight in the coveted list is held by OncoCyte Corporation (OCX) for being among the top performing stocks of 2023. Headquartered in Alameda, CA, United States, the Healthcare sector company is categorized under the industrial sub-sector of Biotech In Vitro In Vivo Diagnostics. Since the start of the year 2023, stock of OncoCyte has so far gained 894.08 percentage, based on the previous year's closing price of $0.32 per share and year-to-date price of $3.19 per share. During the same period, the market capitalization of the company changed from $38.07 million to $26.29 million. The stock of OncoCyte continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, and several other broader level multi-cap market indicators.

PainReform Ltd.

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of PainReform Ltd..
At number nine in the list of top stocks stands PainReform Ltd. (PRFX), which saw a change in its stock price from the level of $0.41 apiece during previous year December end to the price of $3.89 per share as of Sep 15, 2023. It translates to a change of 842.57 percentage. The Tel Aviv, Israel-headquartered Healthcare sector company also saw its market value change from $4.39 million to $6.06 million.

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Bluejay Diagnostics, Inc..
The Acton ,United States-based Bluejay Diagnostics, Inc. (BJDX) belongs to the Healthcare sector and is categorized as a Medical Devices company. The stock of Bluejay Diagnostics, Inc. ended the previous year at a price of $0.38 per share. As of Sep 15, 2023, the stock price has reached $3.06 apiece, which indicates a change of 705.69 percent making the company rank among the top performing stocks of the Healthcare Penny for the year 2023 till date. At the end of the last year, company's market capitalization stood at $7.65 million. It has now changed to $3.79 million as of writing.

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.